NCT04534153View on ClinicalTrials.gov

Excipient Effect on Drug Absorption in Humans

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

June 18, 2025

Study Completion Date

August 18, 2025

Conditions
The Impact of Excipients on Drug Absorption
Interventions
DRUG

Fexofenadine Hydrochloride without sodium lauryl sulfate

without sodium lauryl sulfate

DRUG

Fexofenadine Hydrochloride with sodium lauryl sulfate

with sodium lauryl sulfate

Trial Locations (1)

94143

Ucsf Ctsi Crc, San Francisco

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of California, San Francisco

OTHER